↑ Powrót do 3rd conference (2013)

agenda 2013


 

 

Third Central European Life Science Investment Conference

Hotel Stary, Krakow, 17&18 October 2013

 

This year’s theme:

“Capital, Management & Collaboration: local & global perspectives”

Agenda correct on 16 October 2013

 

 

16 October 2013

 

 
18.30-20.30 Drinks and early registration opens  

17 October 2013

 
08.00 Registration Opens  
9.30 Welcome
Roland Kozlowski, LSBC (Poland)
Leszek Grabarczyk, The National Centre for Research and Development; NCBR (Poland)
 
9.45 Session: Private and Public VC Investment

Chair: Oliver Murphy, Deloitte (PL)

 
9.45 Talk: European VC and investment trends, Kevin Johnson, Index Ventures (CH)  
10.15 Talk: The European Investment Fund as a fund of funds, Ralf Emmerich, EIF (B)  
10.45 Talk: How to leverage private investments with public funding, Krzysztof Senger Deloitte (PL)  
11.15 Coffee & Networking  

11.45 Session: Private-public partnership and its role in initiating the investment cycle

Chair: Oliver Murphy, Deloitte (PL)

 
11.45 Talk: Private Public Partnership: Bridge VC

Leszek Grabarczyk, The National Centre for Research and Development; NCBR (Poland)

 
12.00 Talk: The role of the Polish Agency for Enterprise Development in funding innovation.
Michal Banka, The Polish Agency for Enterprise Development (Poland)
 
12.15 Public approaches to supporting life sciences in the UK lessons for Central Europe

Mark Treherne UKTI (UK)

 
12.30 Panel Discussion:

The pros and cons of Public Private Partnership and its Role in Assisting Development of Life Sciences Businesses

 

Moderator: Oliver Murphy

Derek Jones, Babraham Research Campus (UK)

Leszek Grabarczyk, The National Centre for Research and Development; NCBR (PL)

Ralf Emmerich, EIF (B)

Mark Treherne UKTI (UK)

 

13.15 Networking lunch
 
14.15 Session: International Collaboration

Chair: Mark Treherne

 
14.15 Talk: Case study – Winning the deal and subsequent collaboration

Phil Gould; Jadara Pharma (UK)

 

 
14.45 Panel Discussion: Winning the deal and subsequent collaboration the do’s and don’ts

 

Moderator: Mark Treherne

Phil Gould; Jadara Pharma (UK)

Pawel Przewiezlikowski, Selvita (Poland)

Barry Kenny, Heptares (UK)

Johannes Zanzinger, Boehringer Ingelheim Pharma GmbH & Co. (KG)

Charles Brigden, Amgen (US)

 

 
15.30 TEA & Networking

 

 
16.15 Panel Discussion: The far east scene and gaining investment from the far east it is possible for capital intensive CE businesses

 

Moderator: Philip Gould (UK)

Ajoy Khandheria, Global Asia Partners (India)

Sven Rohmann, Burrill & Company, Burril (D)

Jian Cao, RTC Innovation Ltd (UK)

Stephen Rhind, Propharma Partners (UK)

 
17.00 Conference close for the day

 

 
19.15 Networking drinks and Conference Dinner

 

18 October 2013

 

 
08.00 Round table discussion alternative forms of protecting pharmaceutical intellectual property + breakfast for around 25 people

Przemysław Walasek, Taylor Wessing (Poland)

 
Session Starts 9.15:  Biologics – an opportunity for Central Europe

Chair: Bartosz Walter, Polish Academy of Sciences (PL)

 
9.15 Talk: The Biologics Scene

Maria Bednarek, Medimune (US/UK)

 
9.45 Panel Discussion: Biologics the future an opportunity for Central Europe; innovation or collaboration?

 

Moderator: Roland Kozlowski

Kevin FitzGerald; Activiomics (UK)

Maria Bednarek, Medimune (US/UK)

Johannes Zanzinger, Boehringer Ingelheim Pharma GmbH & Co. (KG)

Piotr Zien, Polpharma (PL)

 

10.30
Organisation Presentations:

 

Kare Riis Nielsen,

Talk: Biobased Industries Consortium (Novozymes) (B)

 

Ferenc Marofka; European Commission (B)

Talk: Horizon 2020: What is in for life sciences in  Central Europe?

 

11.00 Coffee and Networking  
11.30 Company presentations:

Chair: Bartosz Walter, Polish Academy of Sciences (PL)

 

Proteon Sp. z o.o.

Blirt S.A.

Numed Sp. z o.o.

 

 
12.15 Panel Discussion: The big picture – bringing it all together how to make money in life sciences.

 

Moderator: Roland Kozlowski

Antoine Papiernik, Sofinnova (France)

Marek Orlowski, Orenore (Poland)

John Miliad, NBGI Ventures (UK)

Bill Mason, Sage Healthcare (UK)

 
13.15 Summing up
Roland Kozlowski, LSBC (PL) & Oliver Murphy, Deloitte (PL)
 
13.30 Conference Close